相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity
Jia-yi He et al.
ACTA PHARMACOLOGICA SINICA (2022)
1-Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway
Hua Miao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Total coumarin derivates from Hydrangea paniculata attenuate renal injuries in cationized-BSA induced membranous nephropathy by inhibiting complement activation and interleukin 10-mediated interstitial fibrosis
Weida Wang et al.
PHYTOMEDICINE (2022)
Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer
Le Deng et al.
FRONTIERS IN PHARMACOLOGY (2022)
Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study
Lihong Yang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease
Xue-qi Liu et al.
ACTA PHARMACOLOGICA SINICA (2022)
Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice
Gang Cao et al.
ACTA PHARMACOLOGICA SINICA (2022)
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
Xiao-Yong Yu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
Yan-Ni Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
The clinicopathologic spectrum of segmental membranous glomerulopathy
Satoru Kudose et al.
KIDNEY INTERNATIONAL (2021)
Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy
Hyung Ah Jo et al.
KIDNEY INTERNATIONAL (2021)
Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation
Jing-Ru Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Circ_0000524/miR-500a-5p/CXCL16 axis promotes podocyte apoptosis in membranous nephropathy
Zhiqiang Sun et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Long non-coding RNAs: A double-edged sword in aging kidney and renal disease
Yan-Ni Wang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings
Bulent Kaya et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Clinical significance of glomerular C3 deposition in primary membranous nephropathy
Ozgur Akin Oto et al.
JOURNAL OF NEPHROLOGY (2021)
Systems biology in cardiovascular disease: a multiomics approach
Abhishek Joshi et al.
NATURE REVIEWS CARDIOLOGY (2021)
Bioinformatic investigation for candidate genes and molecular mechanism in the pathogenesis of membranous nephropathy
Peng Li et al.
NEPHROLOGY (2021)
Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans
Bingileki F. Lwezaula et al.
BMC NEPHROLOGY (2021)
Natural products: potential treatments for cisplatin-induced nephrotoxicity
Chun-yan Fang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Advances in Membranous Nephropathy
Pierre Ronco et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Perspectives in membranous nephropathy
Nicola M. Tomas et al.
CELL AND TISSUE RESEARCH (2021)
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IκB/NF-κB and Keap1/Nrf2 Signaling Pathways
Liang-Pu Luo et al.
FRONTIERS IN PHARMACOLOGY (2021)
Membranous nephropathy
Pierre Ronco et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy
Lina Wu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes
Zhaocheng Dong et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Herbal Medicine Shulifenxiao Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy
Hailan Cui et al.
FRONTIERS IN PHARMACOLOGY (2021)
Mechanisms of Primary Membranous Nephropathy
Yan Gu et al.
BIOMOLECULES (2021)
Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
Anne-Els Van de Logt et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Comparison of 3 anti-PLA2R inmmunoassaysfor the diagnosis of idiopathic membranous nephropathy in an european population. A pilot study
Israel Nieto-Ganan et al.
CLINICAL IMMUNOLOGY (2021)
Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy
Linda Reinhard et al.
SCIENTIFIC REPORTS (2021)
Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
Shan-Shan Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
Pingna Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
Roxana Jurubita et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Fecal microbiota transplantation for membranous nephropathy
Guanzhou Zhou et al.
CEN CASE REPORTS (2021)
A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients
Catherine Meyer-Schwesinger et al.
KIDNEY INTERNATIONAL (2020)
Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2020)
Ganoderic acid hinders renal fibrosis via suppressing the TGF-β/Smad and MAPK signaling pathways
Xiao-qiang Geng et al.
ACTA PHARMACOLOGICA SINICA (2020)
Ganoderic acid A is the effective ingredient of Ganoderma triterpenes in retarding renal cyst development in polycystic kidney disease
Jia Meng et al.
ACTA PHARMACOLOGICA SINICA (2020)
Antigens, antibodies, and membranous nephropathy: a decade of progress
Syeda Behjat Ahmad et al.
KIDNEY INTERNATIONAL (2020)
Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation
Hua Miao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Wenyang Lishui Decoction Ameliorates Podocyte Injury in Membranous Nephropathy Rat and Cell Models by Regulating p53 and Bcl-2
Huan Lu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Multitissue Multiomics Systems Biology to Dissect Complex Diseases
Xia Yang
TRENDS IN MOLECULAR MEDICINE (2020)
Advances of the experimental models of idiopathic membranous nephropathy
Han Xue Jiang et al.
MOLECULAR MEDICINE REPORTS (2020)
How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?
Zhendong Feng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
Vesna Brglez et al.
FRONTIERS IN MEDICINE (2020)
Proteomic Analysis of Complement Proteins in Membranous Nephropathy
Aishwarya Ravindran et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Advances in Pathogenesis of Idiopathic Membranous Nephropathy
Zhifeng Xu et al.
KIDNEY DISEASES (2020)
Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2020)
Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome
Jun Zhang et al.
MICROBIAL PATHOGENESIS (2020)
A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
Ruijuan Dong et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Efficacy of Chinese Herbal Injections for the Treatment of Primary Nephrotic Syndrome: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Hangxing Yu et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy
Zhaocheng Dong et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Alisol B 23-acetate attenuates CKD progression by regulating the renin-angiotensin system and gut-kidney axis
Hua Chen et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Improvement of membranous nephropathy by inhibition of miR-193a to affect podocytosis via targeting WT1
Jiao Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease
Yuan-Yuan Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy
Christelle Zaghrini et al.
KIDNEY INTERNATIONAL (2019)
Activated NF-κB/Nrf2 and Wnt/β-catenin pathways are associated with lipid metabolism in CKD patients with microalbuminuria and macroalbuminuria
Ya-Long Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB
Ruimin Tian et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease
Ya-Long Feng et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy
Changming Zhang et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
Dan-Qian Chen et al.
NATURE COMMUNICATIONS (2019)
Low serum C3 level, high neutrophil-lymphocyte-ratio, and high platelet-lymphocyte-ratio all predicted poor long-term renal survivals in biopsy-confirmed idiopathic membranous nephropathy
Shang-Feng Tsai et al.
SCIENTIFIC REPORTS (2019)
Aryl hydrocarbon receptor ligands enhance lung immunity through intestinal IKKβ pathways
Tzyy-Bin Tsay et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
microRNAs in chronic kidney disease
Hui Zhao et al.
CLINICA CHIMICA ACTA (2019)
Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers
Amir Taherkhani et al.
PROTEOME SCIENCE (2019)
Metabolomic Analysis of Membranous Glomerulonephritis: Identification of a Diagnostic Panel and Pathogenic Pathways
Amir Taherkhani et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
WNT4 Expression in Primary and Secondary Kidney Diseases: Dependence on Staging
Jolanta Kiewisz et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2019)
Peptide GAM immunoadsorption therapy in primary membranous nephropathy (PRISM): Phase II trial investigating the safety and feasibility of peptide GAM immunoadsorption in anti-PLA2R positive primary membranous nephropathy
Patrick Hamilton et al.
JOURNAL OF CLINICAL APHERESIS (2018)
Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy
Norifumi Hayashi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis
Ming Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Urine proteomics of primary membranous nephropathy using nanoscale liquid chromatography tandem mass spectrometry analysis
Lu Pang et al.
CLINICAL PROTEOMICS (2018)
Efficacy of Traditional Chinese Medicine Regimen Jian Pi Qu Shi Formula for Refractory Patients with Idiopathic Membranous Nephropathy: A Retrospective Case-Series Study
Bin Shi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Network analysis of membranous glomerulonephritis based on metabolomics data
Amir Taherkhani et al.
MOLECULAR MEDICINE REPORTS (2018)
Urinary microbiome of kidney transplant patients reveals dysbiosis with potential for antibiotic resistance
Asha Rani et al.
TRANSLATIONAL RESEARCH (2017)
Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
Dan-Qian Chen et al.
REDOX BIOLOGY (2017)
Autoimmune Thyroiditis and Glomerulopathies
Domenico Santoro et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
New antigenic epitopes in membranous nephropathy
Pierre Ronco et al.
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE (2017)
Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor
Jessy J. Alexander et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Immunology of membranous nephropathy: from animal models to humans
R. A. Sinico et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease
Katryna Cisek et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN)
Antonella Radice et al.
AUTOIMMUNITY REVIEWS (2016)
TGF-β: the connecting link between nephropathy and fibrosis
Brijesh Sutariya et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms
Corrado Murtas et al.
JOURNAL OF NEPHROLOGY (2016)
THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity
Christopher P. Larsen et al.
MODERN PATHOLOGY (2016)
Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy
Takayuki Fujino et al.
BMC NEPHROLOGY (2016)
Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy
Dorin-Bogdan Borza
FRONTIERS IN IMMUNOLOGY (2016)
Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression
Hua Chen et al.
REDOX BIOLOGY (2016)
Down-regulation of miR-186 contributes to podocytes apoptosis in membranous nephropathy
Wen-gang Sha et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Comparative proteomic analysis of membranous nephropathy biopsy tissues using quantitative proteomics
Weiguo Sui et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review
Andreas Kronbichler et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Urinary Xist is a potential biomarker for membranous nephropathy
Yen-Sung Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
ChIP-seq analysis of histone H3K9 trimethylation in peripheral blood mononuclear cells of membranous nephropathy patients
W. G. Sui et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2014)
UPLC-MSE application in disease biomarker discovery: The discoveries in proteomics to metabolomics
Ying-Yong Zhao et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology
Wenbiao Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Efficacy and Safety of Traditional Chinese Medicine (Shenqi Particle) for Patients With Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Clinical Trial
Yiping Chen et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Metabolomics in chronic kidney disease
Ying-Yong Zhao
CLINICA CHIMICA ACTA (2013)
The primary glomerulonephritides: a systems biology approach
Song Jiang et al.
NATURE REVIEWS NEPHROLOGY (2013)
Distinct Metabolic Profile of Primary Focal Segmental Glomerulosclerosis Revealed by NMR-Based Metabolomics
Xu Hao et al.
PLOS ONE (2013)
Astragaloside IV Attenuates Complement Membranous Attack Complex Induced Podocyte Injury Through the MAPK Pathway
Rong Zheng et al.
PHYTOTHERAPY RESEARCH (2012)
Nephrotic Syndrome and Subepithelial Deposits in a Mouse Model of Immune-Mediated Anti-Podocyte Glomerulonephritis
Catherine Meyer-Schwesinger et al.
JOURNAL OF IMMUNOLOGY (2011)
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens
Maurizio Bruschi et al.
JOURNAL OF PROTEOMICS (2011)
Proteinuria induced by anti-dipeptidyl peptidase IV (gp108); role of circulating and glomerular antigen
Y. NATORI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Treatment of idiopathic membranous nephropathy with the herb Astragalus membranaceus
Mohammed S. Ahmed et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
Serial changes in urinary proteome profile of membranous nephropathy: Implications for pathophysiology and biomarker discovery
Heidi Hoi-Yee Ngai et al.
JOURNAL OF PROTEOME RESEARCH (2006)